Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss of $0.37
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Net loss applicable to common shareholders: -3M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Net loss applicable to common shareholders: -3M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q3 EPS of ($0.37), versus ($0.43) reported last year.
For earnings history and earnings-related data on Cyclacel Pharmaceuticals, Inc. (CYCC) click here.
For earnings history and earnings-related data on Cyclacel Pharmaceuticals, Inc. (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- MongoDB stock tumbles despite earnings beat on profit-taking
- Oracle (ORCL) PT Lowered to $290 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
